Bridging the Gap: Comprehensive Osteoporosis Care in Primary Practice-Section 2

Video Transcription

Video Summary

The video discusses guideline-based management strategies for osteoporosis, starting with universal recommendations such as counseling on fracture risks, maintaining a calcium-rich diet, and ensuring adequate vitamin D intake. Regular weight-bearing exercises, avoiding tobacco, and minimizing alcohol consumption are emphasized. The video outlines laboratory evaluations including metabolic panels and hormonal assessments to aid in diagnosis. For treatment, the focus is on goal-directed therapy to increase bone density and prevent fractures. Patients are categorized by risk levels with treatment tailored accordingly, focusing on reducing fracture risks and improving bone density targets. <br /><br />The presentation covers various osteoporosis treatments, beginning with antiresorptive therapies like bisphosphonates (e.g., alendronate, zoledronic acid) and SERMs (e.g., raloxifene), along with their efficacy and side effects. Denosumab, an antibody treatment, is noted for its efficacy in reducing fractures among high-risk patients and is suitable for those with chronic kidney disease. <br /><br />Anabolic therapies, such as teriparatide and abaloparatide, stimulate bone formation and are suitable for high-risk patients but have specific usage guidelines to avoid serious adverse effects. Romosozumab, a newer dual-action drug, shows promise in improving bone density significantly. The video concludes with treatment strategies and the importance of sequencing therapies for optimal fracture prevention.

Keywords

osteoporosis management

fracture prevention

bone density

antiresorptive therapies

anabolic therapies

calcium and vitamin D

treatment strategies